Long-Term Debt Volume: Stoke Corp (STOK)

Graphic logo of Stoke Therapeutics Inc (STOK)

Stoke Therapeutics (STOK) automates the creation of gene therapies using AI algorithms and robotics, as confirmed by the stock's price chart, where long-term debt is recorded at 0.00. The business relies on a method of stimulating protein production within the body to combat pathologies. Positive treatment results for Dravet syndrome serve as the primary driver, while the potential for new epilepsy indications is still emerging.

Stoke - STOK Company Long-Term Debt (period 07/04/2022 - 10/29/2026)

Stoke (STOK) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price stoketherapeutics.com|STOK - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Stoke Therapeutics|STOK - Real Price to Acquire Entire Company
- balance sheet equity data:
Book Price of a Share Stoke Therapeutics|STOK - Company Book Value|Market-to-Book Ratio stoketherapeutics.com|STOK - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital Stoke Therapeutics|STOK - Long-Term Debt to Capital|Current Liabilities to Capital Stoke Corp|STOK - Company Total Debt|Debt to Net Assets Ratio Stoke Therapeutics|STOK - Company Long-Term Liabilities|Amount of Current Liabilities Stoke Therapeutics|Intermediate Coverage Ratio stoketherapeutics.com
- financial results and valuation multiples details:
STOK - Net Profit
Fundamental company valuation:stoketherapeutics.com
Original product of Stoke Therapeutics, Inc.

To assess an asset's financial stability, it is essential for an investor to analyze the structure of liabilities with maturities exceeding one year. This long-term debt metric for Stoke Therapeutics (STOK) aggregates all credit obligations, determining the balance between investment leverage and risks associated with rising rates, which is critical for Stoke Therapeutics as it finances the development of RNA drugs and clinical trials for its flagship STK-001.

Competitor analysis for Stoke Therapeutics

Company Long-Term Debts Tempus Labs TEM|QGEN - Company Long-Term Debt|Long-Term Debt Volume Ionis Pharmaceuticals, Inc. IONS|RGEN (Repligen Corp.) - Company Long-Term Liabilities|RNA: Amount of Long-Term Liabilities|Company Long-Term Debt CRISPR Therapeutics AG|Long-Term Debt genedx.com WGS|Company Long-Term Debt Ultragenyx (RARE)|Company Long-Term Debts Beam Therapeutics Inc (BEAM)|Company Long-Term Debts SRPT (Sarepta Therapeutics Inc)|Twist Bioscience Corp (TWST) - Long-Term Debt|TXG: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings NTLA (intelliatx.com)|BLFS (BioLife Solutions) - Company Long-Term Liabilities|WVE: Amount of Long-Term Liabilities|MAZE (Maze Tx) - Company Long-Term Debts|SION: Company Long-Term Loans and Borrowings|Company Long-Term Debts PRME|TSHA - Long-Term Debt|Company Long-Term Debt uniQure QURE|Company Long-Term Loans and Borrowings MGTX|Regenxbio - Company Long-Term Debts|SLDB - Company Long-Term Debts|Ocugen, Inc. (OCGN) - Company Long-Term Debt|Long-Term Liabilities PACB (pacb.com)|BNTC (Benitec Biopharma) - Company Long-Term Debts|Long-Term Debt Design Therapeutics Inc DSGN|Company Long-Term Liabilities RCKT (Rocket Pharmaceuticals Inc)|Company Long-Term Debts 4D Molecular Corp (FDMT)|Lexeo Therapeutics, Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities KRRO (Korro Bio Inc.)|Editas Medicine - Company Long-Term Debts|Long-Term Debt Volume Silence Therapeutics PLC SLN|PRQR: Company Long-Term Debts|Company Long-Term Liabilities Codexis|Company Long-Term Debt Sangamo Therapeutics|Nautilus Biotechnology Inc (NAUT) - Long-Term Debt Volume|Company Long-Term Debt Metagenomi (MGX)|Long-Term Debt Volume Precision BioSciences Inc.|Generation Bio - Company Long-Term Liabilities|Amount of Long-Term Liabilities BOLD (Boundless Bio Inc)|XCUR - Company Long-Term Debt|Long-Term Debt Imunon, Inc.|phiopharma.com (PHIO) - Company Long-Term Debt|Mustang Bio (MBIO) - Company Long-Term Debts|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Company Long-Term Indebtedness BNGO (Bionano)|Company Long-Term Debt Applied DNA Sciences (APDN)|bluebirdbio.com - Company Long-Term Indebtedness|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Company Long-Term Debts Omega Therapeutics Inc OMGA|OMIC - Company Long-Term Debt|Long-Term Debt Volume Regulus RGLS|SYRS (Syros Pharmaceuticals) - Company Long-Term Liabilities|TBIO: Amount of Long-Term Liabilities|Company Long-Term Debt TRACON Pharmaceuticals, Inc.|Long-Term Debt Unity Biotechnology Inc. UBX